- CRS Publications
- News
News
Authors:
Date:
PRNewswire: August 29, 2016 – STANS, Switzerland, Aug. 29, 2016 – NLS Pharma Group (NLS) announced today that it has initiated enrollment for its “Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR)…
Authors:
Date:
Business Wire: August 25, 2016 – PALM BEACH GARDENS, FL, U.S.A. – Transdermal Delivery Solutions Corporation (TDSC), www.TDSC.us, announced today that transdermal delivery veteran Wallace K. “Wally” Reams has joined its Board of Advisors.
Reams (www.linkedin.com/in/wreams) led the acquisition of…
Authors:
Date:
PRNewswire: August 25, 2016 – WAYNE, PA, U.S.A. – Egalet Corporation (Nasdaq: EGLT) (“Egalet”), a fully integrated specialty pharmaceutical company focused on developing, manufacturing, and commercializing innovative treatments for pain and other conditions, today announced that researchers will…
Authors:
Date:
PRNewswire: August 1, 2016 – MOUNTAIN VIEW, CA, U.S.A. – Based on its recent analysis of the food encapsulation market, Frost & Sullivan recognizes Innovative Food Processors, Inc. (IFP) with the 2016 North America Frost & Sullivan Award for Technology Innovation. IFP’s proprietary PrimeCAP…
Authors:
Date:
PRNewswire: July 20, 2016 – PHILADELPHIA, PA, U.S.A. – Lannett Company, Inc. (NYSE: LCI) today announced that its strategic partner, Sparsha Pharma USA, Inc., has received an acceptable for filing letter from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA…
Authors:
Date:
PRNewswire: July 20, 2016 – SAN FRANCISCO, CA, U.S.A. – Scientists at Shasqi, Inc. and SUNY University at Albany have published research demonstrating a way to target drugs to specific areas of the body, enabling greater efficacy and fewer side effects. The method, called local drug activation,…
